Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis

Journal of Leukocyte Biology

Volumn 78, Issue 2, 2005, Pages 372-382

  Scottà, Cristiano ^a   Tuosto, Loretta ^a   Masci, Anna Maria ^b,c   Racioppi, Luigi ^b   Piccolella, Enza ^a   Frasca, Loredana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Altered peptide ligands; HCV infection; Spectratyping; T cell deletion

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; LIPOCORTIN 5; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; HELPER CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS MUTANT;

ANTIGENS, CD95; ANTIGENS, VIRAL; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; EPITOPES, T-LYMPHOCYTE; HEPACIVIRUS; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SERPINS; T-LYMPHOCYTE SUBSETS; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 23044459614     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0804456     Document Type: Article

References (33)

1. Hunziker, L., Recher, M., Ciurea, A., Martinic, M. M. A., Odermatt, B., Hengarter, H., Zinckernagel, R. M. (2002) Antagonistic variant virus prevents wild-type virus-induced lethal immunopathology. J. Exp. Med. 196, 1039-1046.
2. + T cell reactivity. J. Med. Virol. 72, 370-376.
3. + T cells: the great escape. Nat. Med. 7, 777-778.
4. Hahn, Y. S. (2003) Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? Curr. Opin. Immunol. 15, 443-449.
5. Alter, H. (1995) To C or not to C: these are the questions. Blood 85, 1681-1695.
6. Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., Walker, C. M. (2003) HCV persistence and immune evasion in the absence of T cell help. Science 302, 659-662.
7. Racanelli, V., Rehermann, B. (2003) Hepatitis C virus infection: when silence is deception. Trends Immunol. 24, 456-464.
8. Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., De Carli, M., Fiaccadori, M., Ferrari, C. (1994) Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410.
9. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lallo, D., Kippe, B., Rosemberg, W., Boyd, D., Edwards, A., et al. (1994) Cytotoxic T cells activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369, 403-407.
10. Sewell, A. K., Harcourt, G. C., Goulder, P. J. R., Price, D. A., Phillips, R. E. (1997) Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1-altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. Eur. J. Immunol. 27, 2323-2329.
11. Kaneko, T., Moriyama, T., Udaka, K., Hiroishi, K., Kita, H., Okamoto, H., Yagita, H., Okumura, K., Imawari, M. (1997) Impaired induction of cytotoxic T lymphocytes by antagonism of a weak borne by a variant hepatitis C virus epitope. Eur. J. Immunol. 27, 1782-1787.
12. Gilbert, S. C., Plebanski, M., Gupta, S., Morris, J., Cox, M., Aidoo, M., Kwiatkowski, D., Greenwood, B. M., Wxhittle, H. C., Hill, A. V. S. (1998) Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279, 1173-1177.
13. + T cells. J. Immunol. 163, 650-658.
14. Frasca, L., Scottà, C., Del Porto, P., Nicosia, A., Pasquazzi, C., Versace, I., Masci, A. M., Racioppi, L., Piccolella, E. (2003) Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes. Hepatology 38, 653-663.
15. Plebanski, M., Lee, E. A., Hannan, C. M., Flanagan, K. I., Gilbert, S. C., Gravenor, M. B., Hill, A. V. (1999) Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T cell priming. Nat. Med. 5, 565-571.
16. Di Somma, M. M., Somma, F., Montani, M. S., Mangiacasale, R., Cundari, E., Piccolella, E. (1999) TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis. J. Immunol. 162, 3851-3858.
17. short. J. Immunol. 172, 2194-2200.
18. Van Parijs, L., Peterson, D. A., Abbas, A. K. (1998) The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8, 265-274.
19. Thome, M., Tschopp, J. (2001) Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1, 50-58.
20. Chmielowski, B., Pacholczyk, R., Kraj, P., Kisielow, P., Ignatowicz, L. (2002) Presentation of antagonist peptides to naïve T cells abrogates spatial reorganization of class II MHC peptide complexes on the surface of dendritic cell. Proc. Natl. Acad. Sci. USA 99, 15012-15017.
21. Ehrlich, L. I. R., Ebert, P. J. R., Krummel, M. F., Weiss, A., Davies, M. M. (2002) Dynamics of p56lck translocation to the T cell immunological synapse following agonist and antagonist stimulation. Immunity 17, 809-822.
22. Smyth, L. A., Ardouin, L., Williams, O., Norton, T., Tybulewicz, V., Kioussis, D. (2002) Inefficient clustering of tyrosine-phosphorylated proteins at the immunological synapse in response to an antagonist peptide. Eur. J. Immunol. 32, 3386-3394.
23. Pitcher, L. A., Ohashi, P. S., Van Oers, N. S. (2003) T cell antagonism is functionally uncoupled from the 21- and 23-kDa tyrosine-phosphorylated TCR ζ subunits. J. Immunol. 171, 845-852.
24. Gascoigne, N. R. J., Zal, T. (2004) Molecular interactions at the T cell antigen presenting cell interface. Curr. Opin. Immunol. 16, 114-119.
25. Scaffidi, C., Schmitz, I., Krammer, P. H., Peter, M. E. (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274, 1541-1548.
26. + T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J. Immunol. 168, 1060-1068.
27. Yassai, M., Naumovo, E., Gorski, J., eds. (1997) Generation of TCR Spectratypes by Multiplex PCR for T Cell Repertoire Analysis, Landes Bioscience, Austin, TX.
28. Anderton, M. S., Manickasingham, S. P., Burkhart, C., Luckcuck, T. A., Holland, S. J., Lament, A. G., Wraith, D. C. (1998) Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J. Immunol. 161, 3357-3364.
29. Frasca, L., Tamir, A., Jurcevic, S., Marinari, B., Monizio, A., Sorrentino, R., Carbonari, M., Piccolella, E., Lechler, R. I., Lombardi, G. (2000) Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation 70, 631-640.
30. + T cells in HCV-infected individuals responsive to IFN-α treatment. Virology 269, 313-324.
31. Salmon, M., Pilling, D., Borthwick, N. J., Viner, N., Janossy, G., Bacon, P. A., Akbar, A. N. (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24, 892-899.
32. Opferman, J. T., Korsmryer, S. J. (2003) Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4, 410-415.
33. Mirshahidi, S., Korb Ferris, L. C., Sadegh-Nasseri, S. (2004) The magnitude of TCR engagement is a critical predictor of T cell anergy or activation. J. Immunol. 172, 5346-5355.